Enterome Bioscience

Eli Lilly showed its confidence in Scorpion Therapeutics’ precision drug development efforts by agreeing in January to pay up to $2.5bn for the company to access its lead drug candidate, the PI3Kα i

Having inked another deal with Nestle Health Science , microbiome specialist Enterome Bioscience is now weighing up potential merger partners that would give the privately held French firm a listin

The human microbiome is a growing area of therapeutic exploration, especially in the context of infectious and gastrointestinal diseases. The microbiome refers to the collective genomes of the 10-to-1

Paris-based Seventure Partners established its life sciences team back in 2001 and specializes in the convergence of the health and nutrition sectors. Its focus is on the microbiome, which the company